GSK - EXPECTS RECORD SUPPLY OF MORE THAN 50 MILLION DOSES OF ITS INFLUENZA VACCINE FOR THE 2021-2022 SEASON TO THE U.S. MARKET
Gsk - Expects Record Supply Of More Than 50 Million Doses Of Its Influenza Vaccine For The 2021-2022 Season To The U.s. Market
July 23, 2021 at 01:42 pm EDT
Share
Share
